People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

103.24USD
24 Oct 2014
Price Change (% chg)

$2.84 (+2.83%)
Prev Close
$100.40
Open
$99.55
Day's High
$103.31
Day's Low
$99.21
Volume
9,131,573
Avg. Vol
4,693,537
52-wk High
$103.31
52-wk Low
$66.85

Search Stocks

Casey, Michael 

Brief Biography

Mr. Michael D. Casey serves as Lead Independent Director of Celgene Corp. He has served as one of our directors since August 2002, and has been our independent Lead Director since June 2007, the Chairman of the Nominating Committee and a member of the Executive Committee since December 2006, and a member of the Management Compensation and Development Committee (referred to as the Compensation Committee) since April 2006. Mr. Casey was a member of the Audit Committee from August 2002 through December 2006. From September 1997 to February 2002, Mr. Casey served as the Chairman, President, Chief Executive Officer and a director of Matrix Pharmaceutical, Inc. From November 1995 to September 1997, Mr. Casey was Executive Vice President at Schein Pharmaceutical, Inc. In December 1996, he was appointed President of the retail and specialty products division of Schein Pharmaceutical, Inc. From June 1993 to November 1995, he served as President and Chief Operating Officer of Genetic Therapy, Inc. Mr. Casey was President of McNeil Pharmaceutical (a unit of Johnson & Johnson) from 1989 to June 1993 and Vice President, Sales and Marketing for Ortho Pharmaceutical Corp. (a subsidiary of Johnson & Johnson) from 1985 to 1989. Mr. Casey is also a director of Abaxis Inc. Mr. Casey served as a director of Allos Therapeutics, Inc. through January 2010, AVI BioPharma (now Sarepta Therapeutics, Inc.) through June 2010 and Durect Corporation through December 2013.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

20,995,800

Mark Alles

7,502,700

Peter Kellogg

--

Jacqualyn Fouse

7,795,940

Tuomo Patsi

--

Scott Smith

--
As Of 30 Dec 2013
Search Stocks